Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements Of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2018 2,774,394 810,856          
Beginning balance, value at Dec. 31, 2018 $ 2,774 $ 811 $ 168,170,244 $ (153,233,595) $ 253,734 $ (5,281,180) $ 9,912,788
Issuance of common stock and warrants in registered direct offering, net of issuance costs, shares   86,667          
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value   $ 87 2,698,963       2,699,050
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, shares   1,746,666          
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, value   $ 1,747 13,420,203       13,421,950
Issuance of common stock in connection with purchase of in-process research and development, shares   624,995          
Issuance of common stock in connection with purchase of in-process research and development, value   $ 625 3,030,601       3,031,226
Exercise of pre-funded warrants, shares   492,417          
Exercise of pre-funded warrants, value   $ 492 4,517       5,009
Exercise of purchase warrants, shares   1,889,602          
Exercise of purchase warrants, value   $ 1,890 (1,890)        
Issuance of common stock to vendor, shares   7,836          
Issuance of common stock to vendor, value   $ 7 (7)        
Issuance of warrants in connection with reverse stock split, shares            
Issuance of warrants in connection with reverse stock split, value   63,536       63,536
Issuance of common stock to adjust for reverse split rounding, shares   1,442          
Issuance of common stock to adjust for reverse split rounding, value   $ 1 (1)        
Deemed dividend related to Series B Preferred Stock down round provision   5,284,379       5,284,379
Accretion of deemed dividend related to Series B Preferred Stock down round provision   (5,284,379)       (5,284,379)
Share-based expense   683,104       683,104
Common stock awards to vendors   47,427       47,427
Net loss (11,604,778) (11,604,778)
Ending balance, shares at Sep. 30, 2019 2,774,394 5,660,481          
Ending balance, value at Sep. 30, 2019 $ 2,774 $ 5,660 188,116,697 (164,838,373) 253,734 (5,281,180) 18,259,312
Beginning balance, shares at Jun. 30, 2019 2,774,394 949,218          
Beginning balance, value at Jun. 30, 2019 $ 2,774 $ 948 171,352,760 (155,938,245) 253,734 (5,281,180) 10,390,791
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, shares   1,746,666          
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, value   $ 1,747 13,420,203       13,421,950
Issuance of common stock in connection with purchase of in-process research and development, shares   624,995          
Issuance of common stock in connection with purchase of in-process research and development, value   $ 625 3,030,601       3,031,226
Exercise of pre-funded warrants, shares   450,000          
Exercise of pre-funded warrants, value   $ 450 4,050       4,500
Exercise of purchase warrants, shares   1,889,602          
Exercise of purchase warrants, value   $ 1,890 (1,890)      
Issuance of warrants in connection with reverse stock split, shares            
Issuance of warrants in connection with reverse stock split, value   63,536       63,536
Deemed dividend related to Series B Preferred Stock down round provision   1,404,932       1,404,932
Accretion of deemed dividend related to Series B Preferred Stock down round provision   (1,404,932)       (1,404,932)
Share-based expense   232,437       232,437
Common stock awards to vendors   15,000       15,000
Net loss   (8,900,128) (8,900,128)
Ending balance, shares at Sep. 30, 2019 2,774,394 5,660,481          
Ending balance, value at Sep. 30, 2019 $ 2,774 $ 5,660 188,116,697 (164,838,373) 253,734 (5,281,180) 18,259,312
Beginning balance, shares at Dec. 31, 2019 2,774,394 6,092,432          
Beginning balance, value at Dec. 31, 2019 $ 2,774 $ 6,092 188,240,451 (166,008,620) 253,734 (5,281,180) 17,213,251
Exercise of purchase warrants, shares 229,598          
Exercise of purchase warrants, value $ 229 (229)
Issuance of common stock to vendor, shares 1,188          
Issuance of common stock to vendor, value $ 1 (1)
Share-based expense 388,131 388,131
Net loss (9,693,441) (9,693,441)
Ending balance, shares at Sep. 30, 2020 2,774,394 6,323,218          
Ending balance, value at Sep. 30, 2020 $ 2,774 $ 6,322 188,628,352 (175,702,061) 253,734 (5,281,180) 7,907,941
Beginning balance, shares at Jun. 30, 2020 2,774,394 6,323,218          
Beginning balance, value at Jun. 30, 2020 $ 2,774 $ 6,322 188,517,553 (168,141,691) 253,734 (5,281,180) 15,357,512
Share-based expense 110,799 110,799
Net loss (7,560,370) (7,560,370)
Ending balance, shares at Sep. 30, 2020 2,774,394 6,323,218          
Ending balance, value at Sep. 30, 2020 $ 2,774 $ 6,322 $ 188,628,352 $ (175,702,061) $ 253,734 $ (5,281,180) $ 7,907,941